BSECompany Update4d ago · 25 Jul 2026, 02:22 pm
Intimation of Audio Recording of Earnings call pertaining to the Unaudited Financial Results for the quarter ended June 30, 2026
Onesource Specialty Pharma Ltd · 544292
✦ AI SummaryResults
Onesource Specialty Pharma Ltd has made the audio recording of its earnings call for Q1 FY27 available on its website, discussing unaudited financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
19be8faf-7d1c-4b1b-8df0-afc8c0bb64f4.pdf
View document text
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A
Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, Navi Mumbai
560076, India 400703 India
T: +91 80 6784 0738 F: +91 22 2789 2924
T: 91 22 2789 2942
Date: July 25, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G,
Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Bandra (E), Mumbai – 400 051
Scrip Code: 544292 Symbol: ONESOURCE
Dear Sir/ Madam,
Subject: Intimation of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the
quarter ended June 30, 2026
Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we
wish to inform you that the audio recording of Earnings Call held today i.e., July 25, 2026 at 10:00 hrs (IST) for
discussing unaudited financial results of the Company for the quarter ended June 30, 2026, has been made
available on our Company’s website at:
https://www.onesourcecdmo.com/wp-content/uploads/2026/07/Earning_Call_Audio_Recording_for_Q1_FY27.mp3
You are requested to kindly take the same on record.
For and on behalf of
OneSource Specialty Pharma Limited
Trisha A
Company Secretary and Compliance Officer
Membership Number: A47635
OneSource Specialty Pharma Limited
Formerly Stelis Biopharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497